• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » Addiction Treatment

Addiction Treatment
Addiction Treatment RSS Feed RSS

shutterstock_2449533759.jpg

Stimulant Update with Dr. Brian Hurley

April 15, 2024
Noah Capurso, MD and Brian Hurley, MD, MBA, FAPA, DFASAM

In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options.




Read More

CME Post-Test Psychedelic Treatment of Addiction, CATR, April/May/June 2024

April 1, 2024
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

By successfully completing the test you will be awarded a certificate for 2 CME credit.


Read More
Research Update

Opioid Use Disorder Treatment During the Peripartum Period

April 1, 2024
Gregory Nikogosyan, DO
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Gregory Nikogosyan, DO. Dr. Nikogosyan has no financial relationships with companies related to this material.

The last high-quality head-to-head comparison of buprenorphine and methadone during pregnancy was the MOTHER trial, which was published nearly 15 years ago. Here, researchers revisited the question of which medication is better to use in pregnancy in this large, carefully done, retrospective study. The results make a compelling case for buprenorphine. 


Read More
Research Update

Buprenorphine versus Methadone for Prescription Opioid Use Disorder

April 1, 2024
Richard Moldawsky, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

Methadone treatment for OUD typically comes with a high level of supervision whereas buprenorphine is often flexibly dosed and taken at home. Here researchers wanted to know how patients of a closely supervised methadone clinic compared with those taking buprenorphine prescribed in an office setting. The findings might surprise you.


Read More
Clinical Update

Three Buprenorphine Dosing Strategies When Transitioning From Other Opioids

April 1, 2024
Monthe Kofos, DO and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Monthe Kofos, DO. Addiction Psychiatry Fellow, Yale University, New Haven, CT.

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Kofos and Dr. Capurso have no financial relationships with companies related to this material.

The process of starting a patient on buprenorphine, called an induction, can be a bit tricky and puts a patient at risk of a precipitated opioid withdrawal. In this article, we discuss the three most common buprenorphine induction approaches, review the pros and cons of each, and include straightforward guidance that will help you perform a successful buprenorphine induction for your patients.



Read More
Expert Q&A

Ketamine Use and Misuse

April 1, 2024
Keith A. Trujillo, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA2_KeithTrujillo_headshot.jpegKeith A. Trujillo, PhD.  

Emeritus Professor of Psychology, California State University, San Marcos, CA.

Dr. Trujillo has no financial relationships with companies related to this material.

Ketamine and esketamine represent some of the most powerful rapid-acting agents in our armamentarium of treatments for depression. However, ketamine is also an addictive substance, and there is emerging evidence that the widespread use of ketamine may be causing more patient harms than we were previously aware of. Here, Dr. Trujillo discusses how to use ketamine safely in clinical practice.


Read More
psychedilics.png
Expert Q&A

Psychedelics and Addiction

April 1, 2024
Snehal Bhatt, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue
CATR_QA1_SBhatt-_NEWPhoto.pngSnehal Bhatt, MD.

Chief, Addiction Psychiatry; Professor, Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, NM.

Dr. Bhatt has no financial relationships with companies related to this material.

Dr. Bhatt outlines the latest developments in therapeutic uses of psychedelic medications. He highlights the great opportunities as well as the potential drawbacks. He details some of his own work in the use of psilocybin for the treatment of alcohol use disorder and advises clinicians how to discuss psychedelics with their patients.


Read More
Clinical Update

Treating Opioid Use Disorder During Pregnancy

April 1, 2024
Ariadna Forray, MD and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Ariadna Forray, MD. Associate Professor of Psychiatry; Chief of Psychological Medicine Section, Psychiatry; Director, Center for Wellbeing of Women and Mothers; Yale Medical Director, ACCESS Mental Health for Moms, New Haven, CT. 

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Forray and Dr. Capurso have no financial relationships with companies related to this material.

As the overall prevalence of opioid use disorder has increased, so to has the prevalence of opioid use during pregnancy. Opioid use during pregnancy can put both your patient and the baby at risk, making proper treatment with MOUD essential. In this article, we outline the special considerations for the treatment of OUD during pregnancy and discuss how to prescribe MOUD safely. 


Read More
Clinical Update

A Spotlight on Two Emerging Nootropics

February 10, 2024
Jeremy Weleff, DO., Akhil Anand, MD., and Julian J. Raffoul, MD, PhD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Jeremy Weleff, DO. Yale School of Medicine, New Haven, CT; Cleveland Clinic, Cleveland, OH. Akhil Anand, MD. Cleveland Clinic, Cleveland, OH. Julian J. Raffoul, MD, PhD. Vanderbilt University Medical Center, Nashville, TN.

Dr. Weleff, Dr. Anand, and Dr. Raffoul have no financial relationships with companies related to this material.

Nootropics are a broad class of medications encompassing many different mechanisms of action that are marketed as cognitive enhancers. Not only do most nootropics lack evidence of efficacy, but some can have dangerous side effects and addictive potential. Here, we discuss some of the most concerning nootropics being widely used today.


Read More
Research Update

Extended-Release Buprenorphine for Opioid Use Disorder in Correctional Settings

February 1, 2024
Eli Neustadter, MD, MSc.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Eli Neustadter, MD, MSc. Dr. Neustadter has no financial relationships with companies related to this material.

Incarcerated individuals with opioid use disorder are at an especially heightened risk of adverse outcomes.  The period immediately following release is a particularly vulnerable time, with a much elevated risk of fatal overdose. In this study, investigators report on the use of extended-release injectable buprenorphine in a correctional setting.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 49 50 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • OUDFB1e_Cover_Binding.png

    Treating Opioid Use Disorder—A Fact Book (2024)

    All the tools you need to assess and treat patients struggling with opioid use disorder. 
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.